Tim Ashlin

GSK, England, United Kingdom

During my academic and industrial career I have focussed on the field of cell biology and contributed to multiple projects. Since joining GSK I have gained experience in the area of cellular assay development for high throughput screening. I have recently used arrayed CRISPR screening and small molecule screening to deliver target Identification screens for drug discovery across a range of therapeutic areas.

Disclosure information not submitted.

Presentation(s):

• Identification of high-quality tractable targets in primary immune cells: Combining chemogenomic and functional genomic screening technologies.

  Monday, February 5, 2024
  4:00 PM – 4:30 PM EST